Current financial headlines
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
GuruFocus Market update
Chronological news
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Bausch + Lomb BLCO recently announced that its next-generation SeeLyra femtosecond laser has received European CE Mark approval, expanding the company's surgical portfolio in the European market. The platform is designed to provide precision and control during laser-assisted preparation for premium cataract, LASIK flap โฆ
Next-generation platform provides precision and control in laser-assisted preparation for premium cataract, LASIK flap and corneal therapeutic surgeries with live swept source OCT Compact design accommodates today's space-constrained operating rooms Platform mobility, versatile configurations support efficiency, streamlined workflows VAUGHAN, Ontario, September 11, 2026--(BUSINESS WIRE)--Bausch โฆ
Multicenter retrospective case series published in Ophthalmology and Therapy Results demonstrate enVista Aspire and enVista Aspire toric deliver good distance and functional intermediate vision in a majority of patients Study shows these enhanced monofocal lenses can meet digital demands modern cataract patients face This โฆ
Bausch + Lomb stock has delivered a 17.2% return over the past year, yet several valuation checks still flag the shares as cheap relative to an intrinsic value estimate and to market multiples. For investors, the puzzle is why a stock with a high โฆ
Bausch + Lomb BLCO recently announced that two first-in-class pharmaceutical pipeline candidates will advance to the next stages of clinical development following positive trial results. The programs include a dual-action eye drop for dry eye disease that is moving into Phase 3 and BL1332, โฆ
Bausch + Lomb (BLCO) said late Monday it plans to advance two of its pharmaceutical pipeline assets PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade โฆ
[short sale] abluecup Stocks including Apple, Alphabet, Exxon Mobil, and JPMorgan are among the companies with relatively low short interest, according to a screen of stocks with market capitalizations above $2B. The screen includes stocks with short interest between 1% and 2% of shares โฆ
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. What Bausch + Lomb's latest quarter tells you Bausch + Lomb (NYSE:BLCO) drew fresh attention after reporting second quarter 2026 earnings on 29 July, with higher revenue, โฆ
This article first appeared on GuruFocus. Release Date: July 29, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Bausch & Lomb Corp (NYSE:BLCO) reported 8% constant currency revenue growth, showcasing consistent performance across โฆ
Bausch + Lomb (BLCO) came out with quarterly earnings of $0.16 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was โฆ
Revenue of $1.394 Billion Revenue Grew 9% as Reported and 8% on a Constant Currency1 Basis Compared to the Second Quarter of 2025 GAAP Net Loss Attributable to Bausch + Lomb Corporation of $14 Million Adjusted EBITDA (non-GAAP)1 of $241 Million; Adjusted EBITDA Excluding โฆ
Search by ticker symbol or company name and select a result to open its chart.
Start typing to find a stock or ETF.
Choose one or more countries for market search, or include every covered market.
Currently searching United States